CLINICAL AND VIROLOGICAL CHARACTERISTICS AND RETREATMENT OF HCV-INFECTED PATIENTS WITH FAILURE TO MULTIPLE SUBSEQUENT DAA THERAPIES

被引：0

作者：

Dietz, Julia ^{[1
]}

Vermehren, Johannes ^{[1
]}

Peiffer, Kai-Henrik ^{[1
]}

Wietzke-Braun, Perdita ^{[2
]}

Muellhaupt, Beat ^{[3
]}

Schattenberg, Joern ^{[4
]}

Antoni, Christoph ^{[5
]}

Hametner, Stephanie ^{[6
]}

Mauss, Stefan ^{[7
]}

Heinzow, Hauke ^{[8
]}

Graf, Christiana ^{[1
]}

Port, Kerstin ^{[9
]}

Rockstroh, Juergen K. ^{[10
]}

Zoller, Heinz ^{[11
]}

Zizer, Eugen ^{[12
]}

Herrmann, Andreas ^{[13
]}

Zur Wiesch, Julian Schulze ^{[14
]}

Mueller, Tobias ^{[15
]}

Stauber, Rudolf E. ^{[16
]}

Kremer, Andreas ^{[17
,18
]}

Berg, Christoph ^{[19
]}

Zeuzem, Stefan ^{[1
]}

Sarrazin, Christoph ^{[1
,20
]}

机构：

[1] Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany

[2] Univ Hosp Schleswig Holstein, Kiel, Germany

[3] Univ Hosp Zurich, Zurich, Switzerland

[4] Johannes GutenbergUnivers, Univ Med Ctr, Mainz, Germany

[5] Univ Hosp Mannheim, Dept Internal Med 2, Mannheim, Germany

[6] Barmherzige Schwestern Hosp Linz, Dept Internal Med Gastroenterol 4, Linz, Austria

[7] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany

[8] Univ Hosp Munster, Munster, Germany

[9] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany

[10] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany

[11] Med Univ Innsbruck, Internal Med 1, Innsbruck, Austria

[12] Ulm Univ, Dept Internal Med 1, Ulm, Germany

[13] Univ Klinikum Jena, Kiin Inner Med 4, Jena, Germany

[14] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[15] Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, Berlin, Germany

[16] Med Univ Graz, Dept Internal Med, Graz, Austria

[17] Friedrich Alexander Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany

[18] Friedrich Alexander Univ Erlangen Nurnberg, Translat Res Ctr, Erlangen, Germany

[19] Univ Hosp Tuebingen, Tubingen, Germany

[20] St Josefs Hosp Wiesbaden, Wiesbaden, Germany

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1556

引用

页码：937A / 938A

页数：2

共 50 条

[1] Characteristics and retreatment of HCV DAA failure patients: Real-life experience
Ruiz, I.
Fourati, S.
Varaut, A.
Giovanna, S.
Francois, M.
Wlassow, M.
Poiteau, L.
Donati, F.
Soulier, A.
Stephane, C.
Mallat, A.
Pawlotsky, J. -M.
Hezode, C.
JOURNAL OF HEPATOLOGY, 2018, 68 : S277 - S278
[2] HCV resistance-associated substitutions in patients with HCV genotype 4 and failure to DAA combination therapies and implications for a retreatment
Dietz, Julia
Vermehren, Johannes
Susser, Simone
Peiffer, Kai-Henrik
Welzel, Tania M.
Mullhaupt, Beat
Wursthorn, Karsten
Petersen, Joerg
Schattenberg, Jorn M.
Chave, Jean-Philippe
Niederau, Claus
Schmid, Roland M.
von Felden, Johann
Julian, Schulze Zur Wiesch
Moreno, Christophe
von Hahn, Thomas
Berg, Thomas
Berg, Christoph P.
Zeuzem, Stefan
Sarrazin, Christoph
HEPATOLOGY, 2017, 66 : 572A - 573A
[3] Clinical and virological characteristics of patients with chronic hepatitis C virus (HVC) infection and failure to multiple direct acting antiviral (DAA) therapies
Vermehren, J.
Dietz, J.
Schott, E.
Mauss, S.
Rockstroh, J.
Muellhaupt, B.
Zeuzem, S.
Sarrazin, C.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S520 - S520
[4] Erythropoietin adjuvant therapy and sustained virological response in HCV-infected patients
Alavian, S.-M.
Behnava, B.
Tabatabaei, S. V.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (03) : 509 - 510
[5] The development of hepatocellular carcinoma in HCV-infected patients treated with DAA: A comprehensive analysis
Huang, Peng
Liu, Mei
Zang, Feng
Yao, Yinan
Yue, Ming
Wang, Jie
Fan, Haozhi
Zhuo, Lingyun
Wu, Jingjing
Xia, Xueshan
Feng, Yue
Yu, Rongbin
CARCINOGENESIS, 2018, 39 (12) : 1497 - 1505
[6] Comparison of HCV Resistance-Associated Substitutions in Patients Infected with HCV Genotype 3 before and after Failure to Daa Combination Therapies
Dietz, Julia
Vermehren, Johannes
Peiffer, Kai-Henrik
Grammatikos, Georgios
Welzel, Tania
Petersen, Jorg
Matschenz, Katrin
Antoni, Christoph
Muellhaupt, Beat
Mauss, Stefan
Wietzke-Braun, Perdita
Heinzow, Hauke
Durmashkina, Elena
Piecha, Felix
Zur Wiesch, Julian Schulze
Reinhardt, Lars
Neumann-Haefelin, Christoph
Berg, Thomas
Berg, Christoph
Zeuzem, Stefan
Sarrazin, Christoph
HEPATOLOGY, 2018, 68 : 380A - 381A
[7] CLINICAL AND PATHOLOGICAL SPECTRUM OF PERIPHERAL NEUROPATHY IN HCV-INFECTED PATIENTS
Tocco, P.
Ferrari, S.
Mariotto, S.
Cavallaro, T.
Bonetti, B.
Monaco, S.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 31 - 32
[8] THE RISK OF HCV RECURRENCE IN HCV INFECTED PATIENTS TREATED WITH DAA AFTER ACHIEVING A SUSTAINED VIROLOGICAL RESPONSE: A COMPREHENSIVE ANALYSIS
Huang, Peng
Wang, Yan
Holmes, Jacinta A.
Shao, Tuo
Cheng, Zhimeng
Yan, Jiuliang
Tian, Yanzhang
Yu, Rongbin
Jeyarajan, Andre
Zhu, Chuanwu
Yang, Sheng
Lin, Wenyu
Chung, Raymond T.
HEPATOLOGY, 2020, 72 : 545A - 545A
[9] A serum metabolomic analysis of HCV-infected patients successfully treated with IFN-free DAA regimens
Ceccotti, Giorgia
Meoni, Gaia
Tenori, Leonardo
Gragnani, Laura
Fognani, Elisa
Gianni, Elena
Luchinat, Claudio
Zignego, Anna Linda
HEPATOLOGY, 2016, 64 : 378A - 378A
[10] Dendritic cells activation is associated with sustained virological response to telaprevir treatment of HCV-infected patients
Sacchi, Alessandra
Tumino, Nicola
Turchi, Federica
Refolo, Giulia
Fimia, GianMaria
Ciccosanti, Fabiola
Montalbano, Marzia
Lionetti, Raffaella
Taibi, Chiara
D'Offizi, Gianpiero
Casetti, Rita
Bordoni, Veronica
Cimini, Eleonora
Martini, Federico
Agrati, Chiara
CLINICAL IMMUNOLOGY, 2017, 183 : 82 - 90

← 1 2 3 4 5 →